TMO - Lab Equipment Provider Thermo Fisher's Stock Falls On Revised Q4 Outlook CEO Cites Challenging Environment | Benzinga
Thermo Fisher Scientific Inc (NYSE: TMO) posted Q3 revenue of $10.574 billion, down 1% Y/Y, missing the consensus of $10.595 billion. Adjusted EPS of $5.69 beat the consensus of $5.61.
Organic revenue was 3% lower, Core organic revenue growth was 1%, and COVID-19 testing revenue was $0.05 billion.
Revenue from the Life Sciences Solutions Segment declined by 17.9% to $2.43 billion. ...